Nishadil
Signup Signin
Delhi | 25°C (windy) | Air: 185%

We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO

  • Nishadil
  • January 09, 2024
  • 0 Comments
  • 1 minutes read
  • 5 Views
We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO
Bristol Myers Squibb CEO Christopher Boerner joins 'Mad Money' host Jim Cramer to talk recent acquisitions made by the company, what's ahead for BMY and much more.
Sportscorp CEO Marc Ganis talks Tiger Woods splitting with Nike

Sportscorp CEO Marc Ganis talks Tiger Woods splitting with Nike
Being Unfamiliar With Your Oven Settings Is A Recipe For Disaster

Being Unfamiliar With Your Oven Settings Is A Recipe For Disaster
Samsung narrows profit drop in Q4 as chip demand begins rebound

Samsung narrows profit drop in Q4 as chip demand begins rebound
Indian stock market: 8 key things that changed for market overnight Gift Nifty, US bond yields to China policy easing

Indian stock market: 8 key things that changed for market overnight Gift Nifty, US bond yields to China policy easing
Stocks to Watch: Bajaj Auto, Aurobindo Pharma, Tata Motors, Cipla, BEML

Stocks to Watch: Bajaj Auto, Aurobindo Pharma, Tata Motors, Cipla, BEML
JetBlue CEO Robin Hayes to step down, Joanna Geraghty named as replacement

JetBlue CEO Robin Hayes to step down, Joanna Geraghty named as replacement
Buy or sell: Vaishali Parekh recommends three stocks to buy today — January 9

Buy or sell: Vaishali Parekh recommends three stocks to buy today — January 9